Before you sell to, join or invest in Manifold Biotechnologies, Inc.
MentionFox check on Manifold Biotechnologies, Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/manifold-biotechnologies-inc-form-d-24000001
Check Manifold Biotechnologies, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Manifold Biotechnologies, Inc.?
Manifold Biotechnologies, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-03.
Manifold Biotechnologies, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 3, 2024. The filing reports $32.78M sold. Its industry group is Biotechnology. It names Gleb Kuznetsov (Executive Officer, Director), Pierce Ogden (Executive Officer, Director), Jory Bell (Director) (SEC Form D, December 3, 2024).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Manifold Biotechnologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Manifold Biotechnologies, Inc.
Free to see. No signup.
More on the people and the money behind Manifold Biotechnologies, Inc., from the filings we hold.
Get an email when Manifold Biotechnologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Manifold Biotechnologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch Manifold Biotechnologies, Inc. →Get the full cited report on Manifold Biotechnologies, Inc.
What the filing shows about Manifold Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Manifold Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Manifold Biotechnologies, Inc.'s address as 201 Brookline Avenue, Suite 902, Boston, MA 02215.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Manifold Biotechnologies, Inc. See pricing
Manifold Biotechnologies, Inc. is a registered filer with the SEC (CIK 1820326) and has filed since 2024-12-03. 1 filing is on record, the latest on 2024-12-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Manifold Biotechnologies, Inc.'s Form D of 2024-12-03 names Gleb Kuznetsov, Pierce Ogden, Jory Bell and 3 more as its officers, directors or promoters.
Its new offerings report $32.78M sold across 1 offering, as its own filings state.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Gleb Kuznetsov is named as Executive Officer and Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
Pierce Ogden is named as Executive Officer and Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
Jory Bell is named as Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
Jeff Huber is named as Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
Steven Holtzman is named as Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
Steven Kafka is named as Director on the Form D that Manifold Biotechnologies, Inc. filed with the SEC on 3 December 2024, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2024-12-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Manifold Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Manifold Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Manifold Biotechnologies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Manifold Biotechnologies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Manifold Biotechnologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Manifold Biotechnologies, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/manifold-biotechnologies-inc-form-d-24000001